Literature DB >> 26839648

Drug eluting biliary stents to decrease stent failure rates: A review of the literature.

Joseph Shatzel1, Jisoo Kim1, Kartik Sampath1, Sharjeel Syed1, Jennifer Saad1, Zilla H Hussain1, Kabir Mody1, J Marc Pipas1, Stuart Gordon1, Timothy Gardner1, Richard I Rothstein1.   

Abstract

Biliary stenting is clinically effective in relieving both malignant and non-malignant obstructions. However, there are high failure rates associated with tumor ingrowth and epithelial overgrowth as well as internally from biofilm development and subsequent clogging. Within the last decade, the use of prophylactic drug eluting stents as a means to reduce stent failure has been investigated. In this review we provide an overview of the current research on drug eluting biliary stents. While there is limited human trial data regarding the clinical benefit of drug eluting biliary stents in preventing stent obstruction, recent research suggests promise regarding their safety and potential efficacy.

Entities:  

Keywords:  Bile ducts; Cholangiocarcinoma; Endoscopy; Pancreas

Year:  2016        PMID: 26839648      PMCID: PMC4724033          DOI: 10.4253/wjge.v8.i2.77

Source DB:  PubMed          Journal:  World J Gastrointest Endosc


  50 in total

1.  New biliary endoprosthesis less liable to block in biliary infections: description and in vitro studies.

Authors:  F Cetta; R Rappuoli; G Montalto; C Baldi; M Gori; D Cetta; M Zuckermann; A Magnani; R Barbucci
Journal:  Eur J Surg       Date:  1999-08

2.  The biodurability of covering materials for metallic stents in a bile flow phantom.

Authors:  Byoung Wook Bang; Seok Jeong; Don Haeng Lee; Jung Il Lee; Se Chul Lee; Sung-Gwon Kang
Journal:  Dig Dis Sci       Date:  2011-11-19       Impact factor: 3.199

Review 3.  Pancreatic cancer.

Authors:  Manuel Hidalgo
Journal:  N Engl J Med       Date:  2010-04-29       Impact factor: 91.245

4.  Gemcitabine-releasing polymeric films for covered self-expandable metallic stent in treatment of gastrointestinal cancer.

Authors:  Jang Won Lee; Su-Geun Yang; Kun Na
Journal:  Int J Pharm       Date:  2012-02-16       Impact factor: 5.875

5.  The role of bacteria in the blockage of biliary stents.

Authors:  J W Leung; T K Ling; J L Kung; J Vallance-Owen
Journal:  Gastrointest Endosc       Date:  1988 Jan-Feb       Impact factor: 9.427

6.  Porcine feasibility and safety study of a new paclitaxel-eluting biliary stent with a Pluronic-containing membrane.

Authors:  S I Jang; J-H Kim; M Kim; S Yang; E A Jo; J W Lee; K Na; J M Kim; S Jeong; D H Lee; D K Lee
Journal:  Endoscopy       Date:  2012-07-02       Impact factor: 10.093

7.  Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction.

Authors:  P H Davids; A K Groen; E A Rauws; G N Tytgat; K Huibregtse
Journal:  Lancet       Date:  1992 Dec 19-26       Impact factor: 79.321

8.  Effect of endoscopic stenting of malignant bile duct obstruction on quality of life.

Authors:  Olga Barkay; Patrick Mosler; Colleen M Schmitt; Glen A Lehman; James T Frakes; John F Johanson; Tahir Qaseem; Douglas A Howell; Stuart Sherman
Journal:  J Clin Gastroenterol       Date:  2013-07       Impact factor: 3.062

9.  Efficacy of a metallic stent covered with a paclitaxel-incorporated membrane versus a covered metal stent for malignant biliary obstruction: a prospective comparative study.

Authors:  Sung Ill Jang; Jie-Hyun Kim; Jung Whan You; Kwangwon Rhee; Se Joon Lee; Ho Gak Kim; Jimin Han; Im Hee Shin; Sang-Heum Park; Dong Ki Lee
Journal:  Dig Dis Sci       Date:  2012-11-21       Impact factor: 3.199

10.  A prospective, randomized, controlled trial of metal stents for malignant obstruction of the common bile duct.

Authors:  K Knyrim; H J Wagner; J Pausch; N Vakil
Journal:  Endoscopy       Date:  1993-03       Impact factor: 10.093

View more
  8 in total

Review 1.  Advances in stent therapy for malignant biliary obstruction.

Authors:  Xin He; Ying Zhu; Yining Wang; Yuanzhen Hao; Junbo Hong
Journal:  Abdom Radiol (NY)       Date:  2021-01

Review 2.  Influences of Stent Design on In-Stent Restenosis and Major Cardiac Outcomes: A Scoping Review and Meta-Analysis.

Authors:  Omer Burak Istanbullu; Gulsen Akdogan
Journal:  Cardiovasc Eng Technol       Date:  2021-08-18       Impact factor: 2.495

3.  Vorinostat-eluting poly(DL-lactide-co-glycolide) nanofiber-coated stent for inhibition of cholangiocarcinoma cells.

Authors:  Tae Won Kwak; Hye Lim Lee; Yeon Hui Song; Chan Kim; Jungsoo Kim; Sol-Ji Seo; Young-Il Jeong; Dae Hwan Kang
Journal:  Int J Nanomedicine       Date:  2017-10-17

4.  Characterization of biofilms in biliary stents and potential factors involved in occlusion.

Authors:  Chetana Vaishnavi; Jayanta Samanta; Rakesh Kochhar
Journal:  World J Gastroenterol       Date:  2018-01-07       Impact factor: 5.742

5.  Effects of Paclitaxel-conjugated N-Succinyl-Hydroxyethyl Chitosan Film for Proliferative Cholangitis in Rabbit Biliary Stricture Model.

Authors:  Tao Wang; Hao Zou; Yun-Xia Liu; Xiao-Wen Zhang
Journal:  Chin Med J (Engl)       Date:  2018-03-20       Impact factor: 2.628

6.  Feasibility and efficacy evaluation of metallic biliary stents eluting gemcitabine and cisplatin for extrahepatic cholangiocarcinoma.

Authors:  Jing-Bo Xiao; Jun-Yong Weng; Yang-Yang Hu; Gui-Long Deng; Xin-Jian Wan
Journal:  World J Gastroenterol       Date:  2020-08-21       Impact factor: 5.742

Review 7.  Plastic versus metal stents for inoperable gallbladder cancer with hilar biliary obstruction: the jury is still out.

Authors:  Ashish Kumar Jha; Praveen Jha; Sharad Kumar Jha; Ravi Keshari
Journal:  Ann Gastroenterol       Date:  2020-10-12

8.  Gemcitabine-incorporated polyurethane films for controlled release of an anticancer drug.

Authors:  Seong Hoon Choi; Il-Hoon Cho; Sangsoo Park
Journal:  Biomater Res       Date:  2019-11-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.